Chong Kun Dang Holdings

Chong Kun Dang Holdings Corp. is a South Korean holding company based in Seoul. It serves as the holding-company arm of the Chong Kun Dang group. The company’s present structure dates to November 2, 2013, when Chong Kun Dang was split into a holding company responsible for investment operations and a newly established company responsible for pharmaceutical operations. The continuing entity became Chong Kun Dang Holdings, while the new pharmaceutical operating company retained the name Chong Kun Dang. The company’s background is tied to the longer history of the Chong Kun Dang business. The Korean-language account records its origins in 1941 as Gungbon Yakbang, followed by successive name changes before the 2013 corporate separation. This history provides context for the group’s pharmaceutical roots, but the holding company itself is the investment-business entity created by the split. The cited account lists a number of affiliated companies, including Chong Kun Dang, Chong Kun Dang Bio, Chong Kun Dang Health, Kyongbo Pharmaceutical, Chong Kun Dang Industry, and several other entities. The evidence identifies the group structure and its pharmaceutical heritage, but does not specify individual product portfolios, current executives, detailed markets beyond its South Korean base, or ownership and listing information.

The history associated with Chong Kun Dang Holdings reaches back to the business that preceded the modern holding company. The cited Korean-language history dates the establishment of Gungbon Yakbang to May 7, 1941. On May 7, 1946, the business changed its name to Chong Kun Dang Yakbang; on May 7, 1957, it changed its name to Chong Kun Dang Pharmaceutical Company; and on May 7, 1969, it adopted the name Chong Kun Dang. The key structural turning point came on November 2, 2013. Chong Kun Dang was divided into a holding company and a pharmaceutical business company. The continuing corporation became Chong Kun Dang Holdings, responsible for investment operations, while the newly established corporation, Chong Kun Dang, took on the pharmaceutical business. Thus, the 1941 date belongs to the history of the predecessor business, whereas 2013 marks the creation of Chong Kun Dang Holdings in its holding-company role. The Korean-language source identifies Chong Kun Dang, Chong Kun Dang Bio, Chong Kun Dang Health, Kyongbo Pharmaceutical, Chong Kun Dang Industry, Bell E&C, Bell SM, Bellcom, CKD Venture Capital, and Bell I&S among the group’s affiliated companies. The available evidence does not describe subsequent acquisitions, leadership changes, product launches, or other dated developments.

• Predecessor business established as Gungbon Yakbang

• Renamed Chong Kun Dang Yakbang

• Renamed Chong Kun Dang Pharmaceutical Company

• Adopted the name Chong Kun Dang

• Corporate split created Chong Kun Dang Holdings as the investment-business holding company and Chong Kun Dang as the pharmaceutical operating company

A holding company responsible for the investment-business segment of the Chong Kun Dang group.

1. 1종근당홀딩스ko.wikipedia.org
2. 2Chong Kun Dang Holdingswikidata.org
3. 3Chong Kun Dang official websiteckdpharm.com
4. 4종근당홀딩스ko.wikipedia.org